TrialCurrent medical research and opinion2019

Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Priscilla Hollander et al.PubMed ↗Publisher ↗

No numbers read from the abstract.